2020 International Society of Hypertension Global Hypertension Practice Guidelines.

  title={2020 International Society of Hypertension Global Hypertension Practice Guidelines.},
  author={Thomas Unger and Claudio Borghi and Fadi J. Charchar and Nadia A Khan and Neil R. Poulter and Dorairaj Prabhakaran and Agust{\'i}n Jos{\'e} Ramirez and Markus P. Schlaich and George S. Stergiou and Maciej Tomaszewski and Richard D. Wainford and Bryan Williams and Aletta Elisabeth Schutte},
Document reviewers: Hind Beheiry (Sudan), Irina Chazova (Russia), Albertino Damasceno (Mozambique), Anna Dominiczak (UK), Anastase Dzudie (Cameroon), Stephen Harrap (Australia), Hiroshi Itoh (Japan), Tazeen Jafar (Singapore), Marc Jaffe (USA), Patricio Jaramillo-Lopez (Colombia), Kazuomi Kario (Japan), Giuseppe Mancia (Italy), Ana Mocumbi (Mozambique), Sanjeevi N.Narasingan (India), Elijah Ogola (Kenya), Srinath Reddy (India), Ernesto Schiffrin (Canada), Ann Soenarta (Indonesia), Rhian Touyz… 

Revisiting the diagnosis of ‘resistant hypertension’: what should we do nowadays’

Early identification and effective management strategies have the potential to improve hypertension treatment and lower cardiovascular morbidity and mortality of the hypertensives population, especially RH.

2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action

Norm R. C. Campbell 1,2, Paul K. Whelton , Marcelo Orias, Richard D. Wainford , Francesco P. Cappuccio , Nicole Ide, Bruce Neal , Jennifer Cohn, Laura K. Cobb, Jacqui Webster, Kathy Trieu, Feng J.

2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence.

The 2020 global hypertension practice guidelines by the International Society of Hypertension are taken ahead by providing tailored standards of care as ‘Essential’ and ‘Optimal’ in a format that is practical-to-use even in low-resource settings and another noteworthy step forward is the uptitration from low-dose to full-dose combination before addition of a 3rd drug.

Hypertension Control and Guideline-Recommended Target Blood Pressure Goal Achievement at an Early Stage of Hypertension in the UAE

BP goal achievement was suboptimal and BP control efforts should prioritize improving cardiometabolic goals and lifestyle modifications, according to the ACC/AHA, ESC/ESH, NICE, and ISH guidelines.

Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension

Differences in aspects of hypertension management such as the timing of antihypertensive initiation, assessment of comorbidities and cardiovascular risk factors, pharmacological therapy selection, and blood pressure target and reassessment are explored.


Findings support the notion that the prevalence of Liddle syndrome in selected groups of hypertensive patients may indeed not be as low as commonly reported and recommend physiologically individualized therapy based on appropriate use of renin and aldosterone testing.

Antihypertensive medicine use differs between Ghana and Nigeria

The use of antihypertensive medicines (AHM) in Ghana and Nigeria is described using a novel data source and the feasibility of using novel data sources to gain insights on medicines use in the community is shown.

Need for HTA supported risk factor screening for hypertension and diabetes in Nepal: A systematic scoping review

The review was carried out to document the HTA supported evidence of hypertension and diabetes screening, as CVRFs in Nepal, and found that the prevalence of DM/HTN and the proportion of diabetes with various denominators was reported in most studies.


The risk of essential arterial hypertension (EAH) in the Western Ukraine population increased with burdened CVD heredity regardless of genetic factors, DM2, elevated BMI, WC and WHR, but only in women, with the most pronounced correlation in the TT genotype carriers of NOS3 gene and CC genotype patients of GNB3 gene.



[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Document reviewers: Guy De Backer (ESC Review Co-ordinator) (Belgium), Anthony M. Heagerty (UK), Stefan Agewall (Norway), Murielle Bochud (Switzerland), Claudio Borghi (Italy) and Pierre Boutouyrie (France).

Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension

A region-specific (urban and rural parts of north, east, west, and south India) systematic review and meta-analysis of the prevalence, awareness, and control of hypertension among Indian patients have not been done before and about 33% urban and 25% rural Indians are hypertensive.

Ambiguities in the Guidelines for the Management of Arterial Hypertension: Indian Perspective with a Call for Global Harmonization

It is suggested that all the available guidelines should be harmonized with highest level of evidence available to minimize ambiguities associated with management of hypertension.

Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys

  • Bin Goodarz Gretchen A Honor Cristina Rodrigo M Bethle Zhou Danaei Stevens Bixby Taddei Carrillo-Larco SoBin Zhou M. Ezzati
  • Medicine
    The Lancet
  • 2019

Could 130/80 mm Hg Be Adopted as the Diagnostic Threshold and Management Goal of Hypertension in Consideration of the Characteristics of Asian Populations?

The practical feasibility of the 2017 AHA/ACC guidelines for the management of hypertension and the ideal direction of blood pressure (BP) prevention, detection, evaluation, and management for achieving a goal of zero cardiovascular events in Asia is discussed.

Evidence-Based Chinese Medicine for Hypertension

  • Jie WangX. Xiong
  • Medicine
    Evidence-based complementary and alternative medicine : eCAM
  • 2013
The potential benefits and safety of CM for hypertension still need to be confirmed in the future with well-designed RCTs of more persuasive primary endpoints and high-quality SRs, and evidence-based Chinese medicine still has a long way to go.

Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015

In China, there is a high prevalence of hypertension (HTN) and pre-HTN, and awareness, treatment, and control of HTN were low, and management of medical therapy for HTN needs to improve.

Hypertension in Sub-Saharan African Populations

Differences from whites in etiology and therapeutic responses in sub-Saharan African populations are graded and overlapping rather than absolute, and two lifestyle changes that are feasible and should help to stem the epidemic of hypertension in Africa are a decreased salt intake and decreased obesity.

Roadmap to Achieve 25% Hypertension Control in Africa by 2025.